Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand; and distributes specialty pharmaceuticals. Further, it engages in contract logistics services; offers information provision services; health insurance claims review, medical coding dispatch, outsourcing and remote education; and creation of a medical supply database, creation of master product databases for medical facilities. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.
Metrics to compare | MAHLY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMAHLYPeersSector | |
---|---|---|---|---|
P/E Ratio | 12.8x | 12.4x | −0.5x | |
PEG Ratio | −9.41 | 0.16 | 0.00 | |
Price/Book | 0.8x | 1.1x | 2.6x | |
Price / LTM Sales | 0.1x | 0.6x | 3.2x | |
Upside (Analyst Target) | - | 3.6% | 41.7% | |
Fair Value Upside | Unlock | 33.9% | 6.1% | Unlock |